BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30577277)

  • 1. Transforming Growth Factor-β Partially Reversed the Immunosuppressive Effect of Mesenchymal Stem Cells in Mice.
    Zhao J; Qi YJ; Wang X; Jiao Y; Gong HM; Zhang JX; Jiang DY
    Transplant Proc; 2018 Dec; 50(10):3851-3857. PubMed ID: 30577277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects and mechanism of interleukin-17-modified mouse bone marrow mesenchymal stem cells on rejection reaction of allogeneic skin transplantation in mice].
    Ma TX; Xu YW; Jiang DY
    Zhonghua Shao Shang Za Zhi; 2020 Mar; 36(3):234-243. PubMed ID: 32241050
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of immuno-tolerance mechanism of the third-party bone marrow-derived mesenchymal stem cells in allogenic transplantation].
    Qi BD; Meng BX; Yang Y; Liu B; Li CC; Xia W; Guo SZ; Zhang C
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 May; 27(3):207-12. PubMed ID: 21838003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stro-1-positive human mesenchymal stem cells prolong skin graft survival in mice.
    Zhang Y; Zhao D; Tian C; Li F; Li X; Zhang L; Yang H
    Transplant Proc; 2013 Mar; 45(2):726-9. PubMed ID: 23498813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 17 (IL-17)-Induced Mesenchymal Stem Cells Prolong the Survival of Allogeneic Skin Grafts.
    Ma T; Wang X; Jiao Y; Wang H; Qi Y; Gong H; Zhang L; Jiang D
    Ann Transplant; 2018 Aug; 23():615-621. PubMed ID: 30166501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-β-Expressing Mesenchymal Stem Cells Induce Local Tolerance in a Rat Liver Transplantation Model of Acute Rejection.
    Tang J; Yang R; Lv L; Yao A; Pu L; Yin A; Li X; Yu Y; Nyberg SL; Wang X
    Stem Cells; 2016 Nov; 34(11):2681-2692. PubMed ID: 27333806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells prolong the survival of orthotopic liver transplants by regulating the expression of TGF-β1.
    Niu J; Wang Y; Liu B; Yao Y
    Turk J Gastroenterol; 2018 Sep; 29(5):601-609. PubMed ID: 30260784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo.
    Lynch K; Treacy O; Chen X; Murphy N; Lohan P; Islam MN; Donohoe E; Griffin MD; Watson L; McLoughlin S; O'Malley G; Ryan AE; Ritter T
    Mol Ther; 2020 Sep; 28(9):2023-2043. PubMed ID: 32531237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marrow Mesenchymal Stem Cells Effectively Reduce Histologic Changes in a Rat Model of Chronic Renal Allograft Rejection.
    Yu P; Wang Z; Liu Y; Xiao Z; Guo Y; Li M; Zhao M
    Transplant Proc; 2017 Nov; 49(9):2194-2203. PubMed ID: 29149982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Netrin-1 prolongs skin graft survival by inducing the transformation of mesenchymal stem cells from pro-rejection to immune-tolerant phenotype.
    Liu LP; Chen W; Fan Y; Qi BY; Wang Z; Shi BY
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8741-8750. PubMed ID: 31696460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Tolerance of Human Dental Pulp-Derived Mesenchymal Stem Cells Mediated by CD4⁺CD25⁺FoxP3⁺ Regulatory T-Cells and Induced by TGF-β1 and IL-10.
    Hong JW; Lim JH; Chung CJ; Kang TJ; Kim TY; Kim YS; Roh TS; Lew DH
    Yonsei Med J; 2017 Sep; 58(5):1031-1039. PubMed ID: 28792150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement of B7-H1 in mesenchymal stem cells for immune tolerance to cardiac allografts in combination therapy with rapamycin.
    Wang H; Qi F; Dai X; Tian W; Liu T; Han H; Zhang B; Li H; Zhang Z; Du C
    Transpl Immunol; 2014 Aug; 31(2):65-74. PubMed ID: 24978830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Critical Role for TGF-β/Fc and Nonlytic IL-2/Fc Fusion Proteins in Promoting Chimerism and Donor-Specific Tolerance.
    Xu H; Zheng XX; Zhang W; Huang Y; Ildstad ST
    Transplantation; 2017 Feb; 101(2):294-301. PubMed ID: 27306533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recipient bone marrow-derived stromal cells prolong graft survival in a rat hind limb allotransplantation model.
    Ikeguchi R; Kakinoki R; Ohta S; Oda H; Yurie H; Kaizawa Y; Mitsui H; Aoyama T; Toguchida J; Matsuda S
    Microsurgery; 2017 Sep; 37(6):632-640. PubMed ID: 27859595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma.
    Nemeth K; Keane-Myers A; Brown JM; Metcalfe DD; Gorham JD; Bundoc VG; Hodges MG; Jelinek I; Madala S; Karpati S; Mezey E
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5652-7. PubMed ID: 20231466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cardiac allograft rejection in mice using interleukin-35-modified mesenchymal stem cells.
    Wang W; Zhao N; Li B; Gao H; Yan Y; Guo H
    Scand J Immunol; 2019 Apr; 89(4):e12750. PubMed ID: 30664805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin and bone marrow-derived mesenchymal stem cells (BMSCs) affects serum IgE and lung cytokines levels in sensitized mice.
    Mohammadian M; Sadeghipour HR; Jahromi GP; Jafari M; Nejad AK; Khamse S; Boskabady MH
    Cytokine; 2019 Jan; 113():83-88. PubMed ID: 29914792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta (TGFβ) plays a crucial role in prolonging allograft survival in an allodepletion ("pruning") skin transplant model.
    Watson D; Zhang GY; Hu M; Wang YM; Fletcher J; Sartor M; Alexander SI
    Transpl Immunol; 2014 May; 30(4):168-77. PubMed ID: 24746800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of Treg cells.
    Wu R; Liu C; Deng X; Chen L; Hao S; Ma L
    J Cell Mol Med; 2020 Jan; 24(2):1684-1699. PubMed ID: 31782262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced allogeneic skin-graft survival using sCD95L, sCD152, interleukin-10 and transforming growth factor-beta in combination, and comparison with ciclosporin.
    Zheng H; Du G; Zhao R; Tang B; Zhu N
    Clin Exp Dermatol; 2009 Aug; 34(6):721-7. PubMed ID: 19456768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.